GILD logo

Gilead Sciences, Inc. (GILD)

Profile

Full Name

Gilead Sciences, Inc.

Ticker

NASDAQ: GILD

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 22, 1992

Indexes

S&P 500,NASDAQ 100

Website

http://www.gilead.com

Employees

17600

Key Details

Price

$109.64(-4.28%)

Market cap

$136.38B(Mega cap)

Last Dividend

$0.79

TTM Dividend yield

2.85%

Annual revenue

$28.75B(+6.04% YoY)

Annual EPS

$0.38(-91.56% YoY)

PE ratio

23.08

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $109.64
    GILD price is $109.64

    30-Day Relative Volume

    0.74
    GILD 30-day relative volume is 0.74

    Price Performance

    Price Most recent change

    -4.28%
    GILD price was down -4.28% on Jul 11, 2025

    Price YTD change

    +18.7%
    GILD price is up +18.7% since January 1st

    Price 1-year change

    +56.7%
    GILD price is up +56.7% year-on-year

    Price 3-year change

    +74.98%
    GILD price is up +74.98% over the past 3 years

    Price Range

    Price All-time high

    $123.37
    GILD price is currently -11.13% below its historical high of $123.37

    Price 3-year low

    $59.27
    GILD price is currently +84.98% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $136.38B
    GILD market capitalization is $136.38 billion

    Market cap 3-year change

    +73.57%
    GILD market capitalization is up +73.57% over the past 3 years

    Market cap All-time high

    $179.60B
    GILD market capitalization is currently -24.06% below its historical high of $179.60 billion

    Market cap sector rank

    98.68%
    GILD market capitalization is higher than 98.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.15%
    GILD shares outstanding is down -0.15% year-on-year

    Shares Outstanding 3-Year Change

    -0.8%
    GILD shares outstanding is down -0.8% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.33
    GILD beta is 0.33

    200-day SMA

    $99.74
    GILD price is currently +9.93% above its 200-day simple moving average

    50-day SMA

    $107.48
    GILD price is currently +2.01% above its 50-day simple moving average

    RSI

    49.22
    GILD 14-day relative strength index is 49.22

    Volume

    0.74
    GILD 30-day relative volume is 0.74

    ATR

    $2.82
    GILD average true range is $2.82

    10-day Historical Volatility

    30.04%
    GILD 10-day historical volatility is 30.04%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.79
    GILD last dividend was $0.79 per share, with an ex-dividend date of June 13, 2025

    Next Dividend

    -
    GILD next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $3.08
    GILD annual dividend per share is $3.08

    Dividend per share Sector Rank

    83.53%
    GILD annual dividend per share is higher than 83.53% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +2.67%
    GILD annual dividend per share is up +2.67% year-on-year

    Dividend per share 3-Year Change

    +8.45%
    GILD annual dividend per share is up +8.45% over the past 3 years

    Dividend yield

    Dividend yield

    2.81%
    GILD annual dividend yield is 2.81%

    Dividend yield Sector Rank

    64.29%
    GILD annual dividend yield is higher than 64.29% of companies in Healthcare sector

    Other

    Payout ratio

    816.25%
    GILD annual payout ratio is 816.25%

    Dividends paid

    $3.92B
    GILD annual dividends paid is $3.92 billion

    Free cash flow

    $10.83B
    GILD annual free cash flow is $10.83 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $28.75B
    GILD annual revenue is $28.75 billion

    Revenue Analysts estimate

    $28.67B
    GILD annual revenue is currently +0.28% higher than the consensus analysts' forecast

    Revenue 1-year change

    +6.04%
    GILD annual revenue is up +6.04% year-on-year

    Revenue Sector rank

    96.79%
    GILD annual revenue is higher than 96.79% of companies in Healthcare sector

    EPS

    EPS

    $0.38
    GILD annual earnings per share is $0.38

    EPS Analysts estimate

    $7.98
    GILD annual earnings per share is currently -95.24% lower than the consensus analysts' forecast

    EPS 1-year change

    -91.56%
    GILD annual earnings per share is down -91.56% year-on-year

    EPS Sector rank

    86.11%
    GILD annual earnings per share is higher than 86.11% of companies in Healthcare sector

    Profit

    Gross profit

    $22.50B
    GILD annual gross profit is $22.50 billion

    Gross margin

    78.26%
    GILD annual gross profit margin is 78.26%

    Operating profit

    $10.51B
    GILD annual operating income is $10.51 billion

    Operating margin

    36.53%
    GILD annual operating profit margin is 36.53%

    Net income

    $480.00M
    GILD annual net profit is $480.00 million

    Net margin

    1.67%
    GILD annual net profit margin is 1.67%

    Expenses

    Total expenses

    $18.25B
    GILD annual total expenses is $18.25 billion

    Operating expenses

    $12.00B
    GILD annual total operating expenses is $12.00 billion

    Cost of goods sold

    $6.25B
    GILD annual cost of goods sold is $6.25 billion

    Selling, general & administrative expenses

    $6.09B
    GILD annual SGA is $6.09 billion

    Depreciation and amortization

    $2.77B
    GILD annual depreciation & amortization is $2.77 billion

    Interest expense

    $977.00M
    GILD annual interest expense is $977.00 million

    Income tax

    $211.00M
    GILD annual income tax is $211.00 million

    EBIT & EBITDA

    EBIT

    $1.67B
    GILD annual earnings before interest & taxes is $1.67 billion

    EBITDA

    $1.67B
    GILD annual EBITDA is $1.67 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $58.99B
    GILD annual total assets is $58.99 billion

    Non current assets

    $40.99B
    GILD annual long term assets is $40.99 billion

    Current assets

    $18.00B
    GILD annual total current assets is $18.00 billion

    Cash and cash equivalents

    $9.99B
    GILD annual cash & cash equivalents is $9.99 billion

    Accounts receivable

    $4.42B
    GILD annual accounts receivable is $4.42 billion

    Inventory

    $1.71B
    GILD annual inventory is $1.71 billion

    Liabilities

    Total liabilities

    $39.75B
    GILD annual total liabilities is $39.75 billion

    Long term liabilities

    $27.75B
    GILD annual total long term liabilities is $27.75 billion

    Current liabilities

    $12.00B
    GILD annual total current liabilities is $12.00 billion

    Accounts payable

    $833.00M
    GILD annual accounts payable is $833.00 million

    Debt

    Total debt

    $26.71B
    GILD annual total debt is $26.71 billion

    Total debt 1-year change

    +6.9%
    GILD annual total debt is up +6.9% year-on-year

    Long term debt

    $24.90B
    GILD annual long term debt is $24.90 billion

    Short term debt

    $1.81B
    GILD annual short term debt is $1.81 billion

    Equity & Capital

    Shareholders equity

    $19.33B
    GILD annual stockholders equity is $19.33 billion

    Book value

    $19.25B
    GILD annual book value is $19.25 billion

    Retained earnings

    $11.50B
    GILD annual retained earnings is $11.50 billion

    Working capital

    $6.00B
    GILD annual working capital is $6.00 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $10.83B
    GILD annual cash flow from operations is $10.83 billion

    Cash from operations 1-year change

    +35.25%
    GILD annual cash flow from operations is up +35.25% year-on-year

    Cash from investing

    -$3.45B
    GILD annual cash flow from investing activities is -$3.45 billion

    Cash from investing 1-year change

    -52.27%
    GILD annual cash flow from investing activities is down -52.27% year-on-year

    Cash from financing

    -$3.43B
    GILD annual cash flow from financing activities is -$3.43 billion

    Cash from financing 1-year change

    +33.01%
    GILD annual cash flow from financing activities is up +33.01% year-on-year

    CAPEX

    CAPEX

    $523.00M
    GILD annual capital expenditures is $523.00 million

    CAPEX 1-year change

    -10.6%
    GILD annual capital expenditures is down -10.6% year-on-year

    Free Cash Flow

    Free cash flow

    $10.83B
    GILD annual free cash flow is $10.83 billion

    Free cash flow 1-year change

    +45.91%
    GILD annual free cash flow is up +45.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    78.26%
    GILD annual gross profit margin is 78.26%

    Operating margin

    36.53%
    GILD annual operating profit margin is 36.53%

    Net margin

    1.67%
    GILD annual net profit margin is 1.67%

    ROA & ROE

    ROA

    0.79%
    GILD annual return on assets is 0.79%

    ROE

    2.29%
    GILD annual return on equity is 2.29%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    23.08
    GILD price to earnings ratio is 23.08

    PE ratio Sector rank

    47.42%
    GILD price to earnings ratio is higher than 47.42% of companies in Healthcare sector

    PB Ratio

    PB ratio

    7.12
    GILD price to book ratio is 7.12

    PB ratio Sector rank

    85.03%
    GILD price to book ratio is higher than 85.03% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.75
    GILD price to sales ratio is 4.75

    PS ratio Sector rank

    61.66%
    GILD price to sales ratio is higher than 61.66% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $153.41B
    GILD enterprise value is $153.41 billion

    Enterprise value Sector rank

    98.67%
    GILD enterprise value is higher than 98.67% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    15.52
    GILD EV/EBITDA is 15.52

    EV/EBITDA Sector rank

    89.36%
    GILD EV/EBITDA is higher than 89.36% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.50
    GILD annual current ratio is 1.50

    Quick ratio

    1.36
    GILD annual quick ratio is 1.36

    Leverage

    Debt to equity

    0.00
    GILD annual debt to equity ratio is 0.00

    Interest coverage ratio

    1.71
    GILD annual interest coverage ratio is 1.71

    Risk & Stability

    Piotroski F-Score

    7
    GILD piotroski f-score is 7

    Altman Z-Score

    3.03
    GILD altman z-score is 3.03

    Analyst ratings

    Recent major analysts updates

    May 21, 25 Needham
    Hold
    May 5, 25 Mizuho
    Outperform
    Apr 25, 25 Oppenheimer
    Outperform
    Apr 25, 25 Needham
    Hold
    Apr 25, 25 Morgan Stanley
    Overweight
    Apr 17, 25 BMO Capital
    Outperform
    Mar 27, 25 JP Morgan
    Overweight
    Mar 11, 25 Morgan Stanley
    Overweight
    Mar 5, 25 Wells Fargo
    Overweight
    Mar 5, 25 B of A Securities
    Buy

    Institutional Ownership

    Screeners with GILD included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    NASDAQ 100 companies
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Gilead Sciences, Inc.?
    • Does Gilead Sciences, Inc. pay dividends?
    • What sector is Gilead Sciences, Inc. in?
    • What industry is Gilead Sciences, Inc. in?
    • What country is Gilead Sciences, Inc. based in?
    • When did Gilead Sciences, Inc. go public?
    • Is Gilead Sciences, Inc. in the S&P 500?
    • Is Gilead Sciences, Inc. in the NASDAQ 100?
    • Is Gilead Sciences, Inc. in the Dow Jones?
    • When was Gilead Sciences, Inc.'s last earnings report?
    • When does Gilead Sciences, Inc. report earnings?

    What is the ticker symbol for Gilead Sciences, Inc.?

    The ticker symbol for Gilead Sciences, Inc. is NASDAQ:GILD

    Does Gilead Sciences, Inc. pay dividends?

    Yes, Gilead Sciences, Inc. pays dividends. The last payment was $0.79, with an ex-dividend date on June 13, 2025

    What sector is Gilead Sciences, Inc. in?

    Gilead Sciences, Inc. is in the Healthcare sector

    What industry is Gilead Sciences, Inc. in?

    Gilead Sciences, Inc. is in the Drug Manufacturers - General industry

    What country is Gilead Sciences, Inc. based in?

    Gilead Sciences, Inc. is headquartered in United States

    When did Gilead Sciences, Inc. go public?

    Gilead Sciences, Inc.'s initial public offering (IPO) was on January 22, 1992

    Is Gilead Sciences, Inc. in the S&P 500?

    Yes, Gilead Sciences, Inc. is included in the S&P 500 index

    Is Gilead Sciences, Inc. in the NASDAQ 100?

    Yes, Gilead Sciences, Inc. is included in the NASDAQ 100 index

    Is Gilead Sciences, Inc. in the Dow Jones?

    No, Gilead Sciences, Inc. is not included in the Dow Jones index

    When was Gilead Sciences, Inc.'s last earnings report?

    Gilead Sciences, Inc.'s most recent earnings report was on April 24, 2025

    When does Gilead Sciences, Inc. report earnings?

    The next expected earnings date for Gilead Sciences, Inc. is August 8, 2025
    On this page